Navigation Links
NeurogesX to Present at Needham Life Sciences Conference
Date:6/3/2009

r materially due to various risks and uncertainties, including, but not limited to; positive results in clinical trials may not be sufficient to obtain FDA approval; any regulatory approvals which are received may be limited to certain indications; NeurogesX' product candidates may have unexpected adverse side effects or inadequate therapeutic efficacy physician or patient reluctance to use Qutenza or NGX-1998, if approved, or the inability of physicians to obtain sufficient reimbursement for such procedures; potential alternative therapies; maintaining adequate patent or trade secret protection without violating the intellectual property rights of others; and other difficulties or delays in, clinical development, obtaining regulatory approval, market acceptance and commercialization of NeurogesX' product candidates and the advantages of NeurogesX' product candidates over other pain therapies. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission. 

    NeurogesX, Inc.            The Ruth Group
    Stephen Ghiglieri          Sara Pellegrino (investors)
    Chief Financial Officer    (646) 536-7002
    (650) 358-3310             spellegrino@theruthgroup.com

                               Jason Rando (media)/Janine McCargo
                               (646) 536-7025/7033
                               jrando@theruthgroup.com
                               jmccargo@theruthgroup.com


'/>"/>
SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. NeurogesX Receives European Commission Approval for Qutenza(TM)
2. NeurogesX Reports First Quarter 2009 Results
3. NeurogesX to Hold Conference Call to Discuss First Quarter 2009 Financial Results
4. NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting
5. NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update
6. NeurogesX Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
7. NeurogesX to Present at 11th Annual BIO CEO & Investor Conference
8. NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference
9. NeurogesX Reports Third Quarter 2008 Results
10. NeurogesX to Report Third Quarter 2008 Financial Results
11. NeurogesX Submits NDA for NGX-4010 Dermal Capsaicin Patch for Treatment of Postherpetic Neuralgia (PHN)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCal...dthatRandyScott,GenomicHealth,sExecutiveChairman,w...ferenceinNewYorkCityonTuesday,December1,2009at10:0...vedwebcastofthepresentation,visittheInvestorRelati...or.genomichealth.com .Pleaseconnecttothewebsiteatl...
(Date:11/24/2009)... Chemical Abstracts Service ...reports that China,s patent office is now the worl...ons in chemistry. China trailed Japan,s patent off...(WIPO), and the United States Patent and Trademark... the USPTO in 2005, WIPO in 2006, and exceeded Jap...
(Date:11/23/2009)...HAMPAIGN, Ill. You can think of it as origami ve...sity of Illinois have developed a technique for fa...licon structures from thin films by coupling photo...apillary interactions. , The films, only a few mi...not possible with thicker pieces of the same mater...
(Date:11/23/2009)..., INCLINEVILLAGE,Nev.,Nov.23/PRNewswire-FirstCa...ouncedthatNASDAQhasestablishedNovember27,2009asthe...tockholdersresultingfromthesecuritizationtransacti...nDecember15,2009toallstockholdersofrecordonthereco...rshareamountofthedividendat$1.67pershareofcommonst...
Breaking Biology Technology:Genomic Health to Present at Piper Jaffray Health Care Conference 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Water droplets direct self-assembly process in thin-film materials 2PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
...oy, N.Y. Researchers at Rensselaer Polytechnic In...nexpensive, quick-drying polymer that could lead t...miconductor manufacturing and computer chip packag...nd cost savings for conventional photolithography ...siloxane (PES), should also enable a new generatio...
...E, Jan. 28 Cell Therapeutics, Inc.,(CTI) (Nasdaq ...g today,shareholders approved the proxy proposal a...corporation to increase the number of authorized,s...ase the number of,authorized shares of common stoc...co, Chief Financial Officer at CTI, who chaired th...
...ON, Jan. 28 /PRNewswire-FirstCall/ - Quest PharmaT...d that it has signed a,collaborative research agre...velop a combination therapy for the treatment of l...he Company,s lead oncology product,SL052, with var...that,photodynamic therapy (PDT) can augment the th...
Other Biology Technology:New polymer could improve semiconductor manufacturing, packaging 2Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders 2Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 2Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 3
(Date:11/24/2009)...lable in Spanish . , The presence of increa...mmatory substances in the blood, hinders the loss ...arch project of the University of Navarra conducte...School of Pharmacy. , The project, entitled "A n...the control of body weight and inflammation," exam...
(Date:11/23/2009)... community-associated strain of the deadly superbu...ost common antibioticsposes a far greater health t...into hospitals, according to a study in the Decemb...he new threat is easily picked up in fitness cente...ased the overall burden of MRSA within hospitals, ...
(Date:11/23/2009)...3, 2009 - The time of day matters to forest trees ...duced by a research team led by Professor Malcolm ...-principal for research and colleagues in the depa...ge campus. , Capitalizing on their previous wo...search team examined how poplar trees use their 45...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 1Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 2Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 3Lower Drinking Age Linked to Later Life Problems 57675 1Lower Drinking Age Linked to Later Life Problems 57675 2Lower Drinking Age Linked to Later Life Problems 57675 3Cybernetwork to help K State researchers study tallgrass prairie respond to global warming 9982 1Cybernetwork to help K State researchers study tallgrass prairie respond to global warming 9982 2
...The Stowers Institutes Trainor Lab has demonstrate...velopment of the nervous system, a process that re... neural cells with the cycle of cell division that...s regulating these distinct cellular activities ha...be published in the Feb. 15 issue of Development. ...
...MADISON, WI, January 28, 2008 -- As organic farmin...n the industry are increasingly important. In a re...ientists successfully use nitrogen isotopic discri...rtilizers were used on sweet pepper plants. , Sci...y Desarrollo Agrario y Agrario y Alimentario (IMID...
... Virginia Key, Fla.-- The University of Miamis Ros...nnounced today that it has selected Dennis J. McGi...enstiel Award. McGillicuddy, a senior scientist in...eering at the Woods Hole Oceanographic Institution...study of physical-biological interactions in the o...
Other Biology News:Trainor Lab characterizes gene essential for prenatal development of nervous system 2Is it organic or not? 2Oceanographer Dennis J. McGillicuddy, Jr. receives 34th annual Rosenstiel Award 2
Mouse Anti-Mouse Qa-2 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone 695H1-9-9 from BioLegend
27-mer duplex from B-Bridge International
Propidium Iodide Buffer from BioLegend
Luminex 100 Instrument System from Upstate
Biology Products: